Abstract

In spite of the success of vertebroplasty (VP) and balloon kyphoplasty (BKP), which are widely used for stabilizing painful vertebral compression fractures, concerns have been raised about use of poly(methyl methacrylate) (PMMA) bone cements for these procedures since the high compressive modulus of elasticity (E) of the cement is thought to be one of the causes of the higher number of adjacent-level vertebral fractures. Therefore, bone cements with E comparable to that of cancellous bone have been proposed. While the quasi-static compressive properties of these so-called “low-modulus” cements have been widely studied, their fatigue performance remains underassessed. The purpose of the present study was to critically compare a commercial bone cement (control cement) and its low-modulus counterpart on the basis of quasi-static compressive strength (CS), E, fatigue limit under compression-compression loading, and release of methyl methacrylate (MMA). At 24 h, mean CS and E of the low-modulus material were 72% and 77% lower than those of the control cement, whereas, at 4 weeks, mean CS and E were 60% and 54% lower, respectively. The fatigue limit of the control cement was estimated to be 43–45 MPa compared to 3–5 MPa for the low-modulus cement. The low-modulus cement showed an initial burst release of MMA after 24 h followed by a plateau, similar to many other commercially available cements, whereas the control cement showed a much lower, stable release from day 1 and up to 1 week. The low-modulus cement may be a promising alternative to currently available PMMA bone cements, with the potential for reducing the incidence of adjacent fractures following VP/BKP.

Highlights

  • Vertebroplasty (VP) and balloon kyphoplasty (BKP) are widely used treatments for patients who suffer persistent pain due to osteoporotic vertebral compression fractures (Filippiadis et al, 2017; Huang et al, 2020)

  • Further­ more, the complementary test, which consisted in testing the 2-weeks group in PBS at 37 ◦C indicated that compressive strength (CS) was 12% lower (p < 0.04) and E was 89% higher (p < 0.001) for VS, and that CS was 32% lower (p < 0.001) and E was 19% higher (p < 0.001) for VS-linoleic acid (LA), with respect to the same cements when tested in air at room temperature

  • The quasi-static (CS and E) and dynamic compressive properties and the monomer release profile of a novel lowmodulus poly(methyl methacrylate) (PMMA) bone cement proposed for use in VP/BKP (LA-modified PMMA bone cement) were determined

Read more

Summary

Introduction

Vertebroplasty (VP) and balloon kyphoplasty (BKP) are widely used treatments for patients who suffer persistent pain due to osteoporotic vertebral compression fractures (Filippiadis et al, 2017; Huang et al, 2020) These techniques involve the injection of a bone cement, usually based on poly(methyl methacrylate) (PMMA), into the fractured vertebra which relieves the pain, and in some cases may restore its height. Similar results have been attained for PMMA bone cements modified with linoleic acid (LA), which are another promising low-modulus alternative whose functional properties have been thor­ oughly investigated (Holub et al, 2015; Lopez et al, 2014; Robo et al, 2018a, 2021)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call